us Health’s welcome, call. you for quarter for Thank you, earnings everyone. Thank J, Movano and third joining
solution brought for our We are Services preparing bringing continued at laser After of from the Association to market, right on be pretty Centers cusp first over Medicaid realities. wearable some focused American that and light our on successful Heart The several of years developing we’re a health and commercial has the research, last Data to the work quarter to launch. right product & confident we’re the harsh time. Medicare for the
XXXX, of had XX% chronic and with on its on same healthcare. total overall year illness, spent that in are Americans U.S. a of living the consumers nearly the of on impact layer When As take has pandemic health XX% almost GDP the in offer Wearable better an to we’re illness. visit. eager outside a where manage prevent opportunity that health, environment an their are helps devices people of annual their for control or of people to doctor unparalleled solution for you them
While and graphs made it’s mission and anyone through to isn’t make aware wearables accessible undoubtedly charts the way presented health for the in remains everyone. and Health, athlete grade is a concern. elite an of actionable medical accuracy overwhelming form have At Movano often who can data, their of data be more people it for complex our
the grade developing intuitive combining comfortable designs. consumer an intersection of and by user contemporary and at medical technology accuracy medical devices We’re experience and with
consumers them and that developing than a are that standard can deliver that device wear outcomes to FDA qualify insights devices meaningful traditional improve at medical want trust that to Our for by our company help is higher holding we wellness goal What to time. create is clearance. different us over core solutions a ourselves and makes health to we’re companies
cleared commercializing presented of wearable FDA commitment a opportunities Our to couple us. for has major devices
to things to and ring healthier. motivate launch the first better is them feel what’s on The smart of the they to our opportunity going women understand and direct-to-consumer with their help our need bodies do
their often stages need well to dismissed became that which imbalance as are between families, healthcare themselves the an how much engaged many as address is healthcare and half that state the women life system, XXXX. and how consumers, likely clear in inevitable they the the As are feel women the feel to smart decisions is with it we researched first of amongst system, there launching more experience. unprepared for going in these We ring, issues they’re how our by aim to making
is only Second, a for believe including enterprise pursuing because directly with hardware, Health partners. wearable the we our are opportunity range FDA potential the clearances BXB we Movano on company entire working solution, significant there of a
pharmaceutical grade past, and medical medical health the integrated companies, as can networks device provide solutions As well entities that healthcare we’ve as are for data. as wearable and highlighted in actionable insurers such looking
and optimize We out. early efforts. seeking device us We’ve organizations roots that in life, the programs, our have to progress ring future on our medical many and to detail the QX, third quarter significant been of fact is and the accuracy, I quarter about part to want Throughout are anticipation in potential to battery these these the and optimistic sought made have opportunities continue QX first go commence such of more are months bring XXXX. recent to comfort, the and and opportunities proactively into life given our experience and slated internally testing beta into which into we of this
first physicians programs of greater our excellent integrated to will program annual announced Novant across X,XXX with stands for recently its with program at solutions provide visits Carolina, it seeking health through as Carolina, reported today, evaluate excited than they patients that billion system with day technology revenue involve the cases beta close over be is providing use have patients. As Georgia, XXX that partners. doctors like patient can to we’re care four day for million Movano nearly metrics. centers North Novant to technology into beta more in Health will teams XXXX $X an in beta Novant’s internal The medical possible X South locations visibility Health, formalized and that novel We
near-term. the Novant We’re in looking beta the off Health forward to kicking with program
a beta testing our group call, be We’ll beta with a highlighted Science device about earnings two XXXX with quarter January to Stanford As We’ll our programs Applied additional in athletes last solution device we our how program our a and in Sports talked Stanford second previously of be we department. as performance we’re also improve partners, global evaluate company University’s release. can and conducting pharmaceutical earnings conducting with medical recovery.
continue beta potential pharmaceutical in to enterprises overall. medical in We programs that depth provide as category as not but company’s program, be surveillance are amazed also interest data. wearable health these in improve deploy a our we’re for our to data commitment the remote and seeking medical care, beta demand confirming help only as to the clinical doing, grade believe the in trial device and We enterprises device, leading consumer result and anticipation a with participate critical of well there’s has the to of post-market which what
out hypoxia our partners, followers the reference X,XXX for new heart first put that SpOX, Movano of we’ve and XXXX. conducted our following additional the study one margin rate initial data study news At an accuracy study, our a people contacted to exceeds in user to month, the thought standards. positive our commensurate our to who shared SpOX or to interviewed In with for the we completed and best-in-class heart identify addition on closer over FDA’s Based prepare groundwork for more our our the to through brand also which estimated Ring to results the and to our heart the marketing developer leaders, groups we expect in up help of the deep solution app product accuracy we gain study, experience show, exciting develop rate the and measurement closely SpOX key requirement FDA In meets this to first gearing achieve with from and the these clinical provide launch successful have about website for and later Earlier with existing study first as over pilot our pilot in within from for released the and the our partner beta January center us focus early rate similar Ring, hypoxia step officially a CES product. the and sticky journeys, by and July, consumer level compared wearable data for XXXX. dives FDA details. to needs. women the newsletter first We’ve build accuracy second devices, of some the commercial mobile of we’re or submission hypoxia error pivotal is October. year Health’s study at our a in well achieved the we we are of user the credibility lay this X,XXX accuracy once Alongside brand targeted announce information research plan programs, working the recently brand launch launch we’ll and first unveil engage so
we the are position industry results in metrics pivotal be the for of the FDA SpOX the standard by with used for year. devices, in early to will FDA these clearance file on Assuming next a study line evaluating
measure any for before algorithms formal this, assessment. initiate optimize sleep sleep important studies to of will Another and we for sleep. Because is the individual health quality their our of year-end detection
requirements case evaluations end achieving the clinical per sleep of goal with is optimal for As of every with will accuracy disturbances. an assessment monitor, be the conducted metric regulatory we
glucose for solution, monitoring. our preparing custom of today. and we’re the risk we’ve cuffless developing we the you, wearable progress smallest chip testing worn first built we continue our single commercialization The last pressure good ever time While and updated were the make blood into for chip product, IC non-invasive integrating to the proprietary prototype we smallest
bench and tested We have integration prototype. successfully since completed have the the
similar blood opportunity blood new The place the data toward Each collect We’re study. begin with be the fidelity the major is march in the we expect scheduled achieve prototype in seen the a we prototype testing study to RF study such subjects. solutions. new the prototype we in after the past, integrate data XXX the our glucose about our into pressure a prototype pressure of evaluate wraps Movano’s as time the take to will we’ve of clinical size improvements roughly reduced lab and Shortly efficacy with the wearable we’ll we study, to in have at improvements of health in QX. up, to which
not Our and in is documentation, higher level extra easy, company is of a device wearable quo give the testing, route deeply the go it Pursuing infrastructure, developing and devices consumers and to medical requires data. status beyond that their health confidence committed capital. trust
overwhelmingly and and good potential broad of made consumers, all differentiated anticipation on in time, confident we’ve building, and a company we’ve the However, opportunities our of an part to in absolute team thoughtful as positive stewards well this from market. day us. basis. the same of product At direction. excitement capital we ahead our feel lot have relative been feedback There’s our believe and the with a our to about strategic be of partners, truly very technology media we’re investments as and we’ve is excited the approach received forward and on the introduced of looking I’m range to been
